ConductScience.org, home

Paper20150892

Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival.

Drosten M and 9 others. EMBO J, 2010. Cited by 295 papers, by iCite.

Cite this record

ConductScience Library. Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival. Papers, record 20150892. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20150892

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival.
PubMed
Journal
EMBO J
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
295
iCite
Relative citation ratio, by iCite
5.76
iCite
Revised in PubMed
2026-02-04
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Drosten MMatthias
2Dhawahir AAlma
3Sum EYEleanor Y M
4Urosevic JJelena
5Lechuga CGCarmen G
6Esteban LMLuis M
7Castellano EEsther
8Guerra CCarmen
9Santos EEugenio
10Barbacid MMariano

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell ProliferationMajor topic
Signal TransductionMajor topic
ras ProteinsMajor topic
Animals
Cell Movement
Cell Survival
Extracellular Signal-Regulated MAP Kinases
Fibroblasts
Mice
Phosphatidylinositol 3-Kinases
raf Kinases

Source PubMed

Download CSV of topics

References60

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110557073Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins.Oncogene1999https://conductscience.org/library/papers/10557073PubMed
210022812Plasma membrane recruitment of RalGDS is critical for Ras-dependent Ral activation.Oncogene1999https://conductscience.org/library/papers/10022812PubMed
316226508The role of erk1 and erk2 in multiple stages of T cell development.Immunity2005https://conductscience.org/library/papers/16226508PubMed
49199319Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1.Mol Cell Biol1997https://conductscience.org/library/papers/9199319PubMed
59362489Stimulation of gene induction and cell growth by the Ras effector Rlf.EMBO J1997https://conductscience.org/library/papers/9362489PubMed
69150145Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras.Cell1997https://conductscience.org/library/papers/9150145PubMed
79765202Senescence of human fibroblasts induced by oncogenic Raf.Genes Dev1998https://conductscience.org/library/papers/9765202PubMed
814519393Role of Rho-family proteins in cell adhesion and cancer.Curr Opin Cell Biol2003https://conductscience.org/library/papers/14519393PubMed
910558995Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice.Science1999https://conductscience.org/library/papers/10558995PubMed
107651428RAS signalling is abnormal in a c-raf1 MEK1 double mutant.Mol Cell Biol1995https://conductscience.org/library/papers/7651428PubMed
119825675Genetics of RAS signaling in C. elegans.Trends Genet1998https://conductscience.org/library/papers/9825675PubMed
1211257001Analysis of R-Ras signalling pathways.J Cell Sci2001https://conductscience.org/library/papers/11257001PubMed
1310880430The ErbB signaling network: receptor heterodimerization in development and cancer.EMBO J2000https://conductscience.org/library/papers/10880430PubMed
143145408Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP.Mol Cell Biol1988https://conductscience.org/library/papers/3145408PubMed
1517182900Rap1: a key regulator in cell-cell junction formation.J Cell Sci2007https://conductscience.org/library/papers/17182900PubMed
1615950907Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).Cancer Cell2005https://conductscience.org/library/papers/15950907PubMed
1712778136RAS oncogenes: the first 30 years.Nat Rev Cancer2003https://conductscience.org/library/papers/12778136PubMed
1814645534While K-ras is essential for mouse development, expression of the K-ras 4A splice variant is dispensable.Mol Cell Biol2003https://conductscience.org/library/papers/14645534PubMed
1919243428Compartmentalized signalling: Ras proteins and signalling nanoclusters.FEBS J2009https://conductscience.org/library/papers/19243428PubMed
209294608K-ras is essential for the development of the mouse embryo.Oncogene1997https://conductscience.org/library/papers/9294608PubMed

See all 60 referencesDownload CSV of references

Cited by220

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 295 citations.

PMIDTitleJournalYearIn PapersSource
42794624Integrated Analysis of Rat Pulmonary Hypertension Datasets Identifies Candidate circRNA Networks in Hypoxia-Exposed Pulmonary Artery Tissue.Int J Mol Sci2026https://conductscience.org/library/papers/42794624PubMed
42749263A RALGEF inhibitor suppresses lung cancer stem cell development and tumorigenesis.J Biol Chem2026https://conductscience.org/library/papers/42749263PubMed
42709866HRAS promotes mutant NRAS-driven transformation with codon and allele specificity.Sci Signal2026https://conductscience.org/library/papers/42709866PubMed
42653163Targeting Oncogenic KRAS Using Peptide Nucleic Acid Oligomers Attached to Cell-Penetrating Peptides.Int J Mol Sci2026https://conductscience.org/library/papers/42653163PubMed
42649211Oncogenic Kras targeting with MRTX1133 or Daraxonrasib specifically synergize with anti-CTLA4 to promote anti-tumor immunity in pancreatic cancer.Nat Commun2026https://conductscience.org/library/papers/42649211PubMed
42439612Understanding the Role of Fibrotic Scarring in Shaping the Lesion Site and Neural Repair After Spinal Cord Injury.Cells2026https://conductscience.org/library/papers/42439612PubMed
42303154KRAS G12C and KRAS G12D respond to lipid metabolism in an allele-specific manner.J Lipid Res2026https://conductscience.org/library/papers/42303154PubMed
42297776Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis.Nat Commun2026https://conductscience.org/library/papers/42297776PubMed
42201959NF1 and SPRED1/2 cooperate through RAS-MAPK-independent functions.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/42201959PubMed
42200804Targeted KRASG12V Degradation In Vivo Elicits Lung Adenocarcinoma Regression with Subsequent Relapse from Dysregulated Proteolysis.Cancer Res2026https://conductscience.org/library/papers/42200804PubMed
42082482Characterization of KRASG12C inhibitor olomorasib single-agent and combination with activity in KRASG12C-mutant models.Nat Commun2026https://conductscience.org/library/papers/42082482PubMed
42079131Characterization and therapeutic suppression of KEAP1-NRF2-driven resistance to KRAS inhibitors in pancreatic and lung cancer.bioRxiv2026https://conductscience.org/library/papers/42079131PubMed
42054419Computational insights on the molecular interplay between KRas (G12D mutation) and SOS1 modulated by the inhibitor BI-3406.PLoS Comput Biol2026https://conductscience.org/library/papers/42054419PubMed
42017331Revisiting RAS family GTPase signaling: effector selectivity and oncogenic bypass.Biochem J2026https://conductscience.org/library/papers/42017331PubMed
41882629SOS1: tracking the evolving path from promising to actionable therapeutic target in RAS-dependent cancers.Mol Cancer2026https://conductscience.org/library/papers/41882629PubMed
41819089De novo design of Ras isoform selective binders.Cell Chem Biol2026https://conductscience.org/library/papers/41819089PubMed
41685162Targeting oncogenic K-RAS mutants with small-molecule degrader XMU-MP-9 through NEDD4-1.Acta Pharm Sin B2026https://conductscience.org/library/papers/41685162PubMed
41556816KRASG12R-Mutant Pancreatic Cancer Features Limited ERK/MAPK Transcriptional Activity and a Distinctive Tumor Microenvironment.Cancer Res2026https://conductscience.org/library/papers/41556816PubMed
41513618MSLN-mediated activation of EGFR-ERK1/2 signaling drives liver metastasis in breast cancer.Cell Death Discov2026https://conductscience.org/library/papers/41513618PubMed
41340466Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer.Mol Cancer Ther2026https://conductscience.org/library/papers/41340466PubMed

See all 220 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20150892

GET https://conductscience.org/api/papers/v1/20150892/references?page=2